Chen, K., Li, W., Xu, C., Guo, Q., Li, D., Lian, L., Zhou, X., Gu, Y., Fu, W., Duan, W., Wang, R., Zhang, Y. (2025). Sintilimab plus oxaliplatin and capecitabine versus sintilimab plus albumin-bound paclitaxel and capecitabine for advanced unresectable gastric and gastroesophageal junction (GEJ) adenocarcinoma patients: A prospective, randomized, open-label, investigator-initiated phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16042